{"product_id":"cancer-screening-paperback-9780521116947","title":"Cancer Screening (Paperback) 9780521116947","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eCancer Screening\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eThis 1991 publication was organized by the International Union Against Cancer (UICC), a leading agency in the field of cancer epidemiology and control.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eA. B. Miller (Edited by), J. Chamberlain (Edited by), N. E. Day (Edited by), M. Hakama (Edited by), P. C. Prorok (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780521116947, Cambridge University Press\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback, published 9 June 2011\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e458 pages\u003cbr\u003e24.4 x 17 x 2.4 cm, 0.73 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eScreening is regarded as a cost-effective and clinically useful approach for the early diagnosis of several malignancies, especially such common cancers as those of the breast and the cervix. This 1991 is a publication from the Project on evaluation of Screening for Cancer, organized by the International Union Against Cancer (UICC), one of the world's foremost agencies in the field of cancer epidemiology and control. It contains recommendations from the international authorities on cancers for which screening is used. Findings from studies in many countries are presented and evaluated, and methodological issues are also discussed. This is an influential and authoritative statement on the scope of cancer screening. It will be of interest to oncologists, epidemiologists and others in the public health field.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePreface\u003cbr\u003e Part I. Screening for Breast Cancer: State of the Art on Breast Cancer Screening: 1. Sensitivity and specificity of screening in the UK trial of early detection of breast cancer\u003cbr\u003e 2. Screening for breast cancer in Finland\u003cbr\u003e 3. The Swedish two-county trial of mammographic screening for breast cancer: recent results on mortality and tumour characteristics\u003cbr\u003e 4. The Malmö mammographic screening trial\u003cbr\u003e 5. The Canadian national breast screening study\u003cbr\u003e 6. The USSR\/Germany\/WHO BSE study and global strategies for the control of breast cancer\u003cbr\u003e 7. A cost-effectiveness approach to breast cancer screening\u003cbr\u003e 8. Summary of the discussion on breast cancer screening\u003cbr\u003e Part II. Screening for Colorectal Cancer: State of the Art on Screening for Colorectal Cancer: 9. Colon cancer control study: status and current issues\u003cbr\u003e 10. An update on the Nottingham trial of faecal occult blood screening and rescreening of 51 325 subject\u003cbr\u003e 12. Interim report on a randomised trial of screening for colorectal cancer with Hemoccult-II\u003cbr\u003e 13. Case-control evaluation of colorectal cancer screening in the Federal Republic of Germany\u003cbr\u003e 14. Summary of the discussion on colorectal cancer screening\u003cbr\u003e Part III. Screening of Cancer for the Cervix: State of the Art on Screening for Cancer of the Cervix: 15. The natural history of cancer of the cervix, and the implications for screening policy\u003cbr\u003e 16. Effect of organized screening on the risk of cervical cancer in the Nordic countries\u003cbr\u003e 17. The organisation of cervical screening in England and Wales\u003cbr\u003e 18. Indications for colposcopy from a UK viewpoint\u003cbr\u003e 19. Screening for cervix cancer in developing countries\u003cbr\u003e 20. Summary of the discussion on screening for cancer of the cervix\u003cbr\u003e Part IV. Screening for Ovarian Cancer: State of the Art on Screening for Ovarian Cancer: 21. Tumour markers in screening for ovarian cancer\u003cbr\u003e 22. Phase I investigation for early diagnosis of ovarian carcinoma\u003cbr\u003e what problems are to be expected in a larger screening programme?\u003cbr\u003e 23. Screening for ovarian cancer\u003cbr\u003e 24. Summary of the discussion on screening for ovarian cancer\u003cbr\u003e Part V. Screening for Malignant Melanoma: State of the Art on Screening for Melanoma: 25. Screening and early diagnosis for melanoma in Australia and New Zealand\u003cbr\u003e 26. Screening for melanoma in the UK\u003cbr\u003e 27. Screening for melanoma\/skin cancer in the United States\u003cbr\u003e 28. The dysplastic naevus syndrome: implications for screening\u003cbr\u003e 29. Summary of the discussion on screening for melanoma of the skin\u003cbr\u003e Part VI. Screening for Prostate Cancer: State of the Art on Screening for Prostate Cancer: 30. Issue in screening for prostate cancer\u003cbr\u003e 31. Available screening tests for prostate cancer\u003cbr\u003e 32. Evaluation of screening for prostate, lung and colorectal cancers :the PLC trial\u003cbr\u003e 33. Summary of the discussion on screening for cancer of the prostate\u003cbr\u003e Part VII. Screening for Neuroblastoma: State of the Art on Screening for Neuroblastoma: 34. Neuroblastoma: studies in Japan\u003cbr\u003e 35. Screening for neuroblastoma, background, preliminary experience in the North of England and proposals for an evaluative study\u003cbr\u003e 36. Summary of the discussion on screening for neuroblastoma\u003cbr\u003e Part VIII. Screening for Stomach Cancer: State of the Art on Screening for Stomach Cancer: 37. Evaluation of mass screening programme for stomach cancer in Japan\u003cbr\u003e 38. Summary for the discussion of screening for stomach cancer\u003cbr\u003e Part IX. Screening for Nasopharyngeal Cancer: State of the Art on Screening for Nasopharyngeal Cancer: 39. Screening for nasopharyngeal carcinoma\u003cbr\u003e 40. Summary of the discussion on screening for nasopharyngeal cancer\u003cbr\u003e Part X. Methodological Issues: 41. Surrogate measures in the design of breast screening trials\u003cbr\u003e 42. Recent developments in cancer screening modeling\u003cbr\u003e 43. Case-control studies of screening\u003cbr\u003e 44. Summary of the discussion on new approaches to the evaluation of screening.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Cambridge University Press","offers":[{"title":"Default Title","offer_id":46006521594136,"sku":"9780521116947","price":58.57,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780521116947i_9f57e9af-f7aa-422f-b0fc-fbb61ed4a9c5.jpg?v=1691371542","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/cancer-screening-paperback-9780521116947","provider":"Freshly Printed Books","version":"1.0","type":"link"}